CELC - Celcuity Inc.
IEX Last Trade
10.85
0.085 0.783%
Share volume: 428,363
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$10.76
-1.07
-0.09%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-15 | 2023-08-11 | 2023-11-13 | 2024-11-14 | 2024-05-15 | 2024-08-14 | 2024-11-14 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 12.548 M | 15.055 M | 18.898 M | 19.729 M | 22.494 M | 24.283 M | 30.060 M | |
| Selling general and admin | 1.269 M | 1.309 M | 1.410 M | 1.648 M | 1.846 M | 1.786 M | 2.472 M | |
| Research and development | 11.278 M | 13.746 M | 17.488 M | 18.081 M | 20.648 M | 22.497 M | 27.587 M | |
| Total expenses | 12.548 M | 15.055 M | 18.898 M | 19.729 M | 22.494 M | 24.283 M | 30.060 M | |
| 19.99% | 25.52% | 4.40% | 14.01% | 7.95% | 23.79% | |||
| Operating income | -12.548 M | -15.055 M | -18.898 M | -19.729 M | -22.494 M | -24.283 M | -30.060 M | |
| Ebit | -12.548 M | -15.055 M | -18.898 M | -19.729 M | -22.494 M | -24.283 M | -29.792 M | |
| Pretax income | -11.938 M | -14.588 M | -18.405 M | -18.848 M | -21.612 M | -23.722 M | -29.792 M | |
| 22.19% | 26.16% | 2.41% | 14.66% | 9.76% | 25.59% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -11.938 M | -14.588 M | -18.405 M | -18.848 M | -21.612 M | -23.722 M | -29.792 M | |
| -22.19% | -26.16% | -2.41% | -14.66% | -9.76% | -25.59% |